YOUR BUSINESS AUTHORITY
Springfield, MO
The Food and Drug Administration gave the green light to a gene therapy for a rare genetic bleeding disorder created by Pfizer.
Marketed as Beqvez, the drug is for adults with moderate to severe hemophilia B.
The drug has a $3.5 million price tag before insurance and rebates.
Read more from CNBC.
Project work in Springfield corridor will continue into 2031.
Thanksgiving staple recalled at Costco
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
HBA of Greater Springfield executive officer to retire
Transportation officials discuss $471M Forward 44 initiative
Monday Morning Business Leads: Nov. 16, 2026
Former OMB Bank officer placed on probation
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.